22 results
424B5
OCUP
Ocuphire Pharma Inc
14 Aug 23
Prospectus supplement for primary offering
8:00am
controls, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations. Compliance with these legal standards could … activities. Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, contractors, and other partners from
424B5
OCUP
Ocuphire Pharma Inc
7 Jun 21
Prospectus supplement for primary offering
4:21pm
, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations. Compliance with these legal standards could impair its ability … PATRIOT Act, and other state and national anti-bribery and anti-money laundering laws in the countries in which Ocuphire conducts activities. Anti
424B5
fs91qv4 avwdw
11 Mar 21
Prospectus supplement for primary offering
9:19am
424B4
yrduzq3gy41qd
17 Feb 21
Prospectus supplement with pricing info
7:14am
8-K
EX-14.1
dp79cljz hv88r
6 Nov 20
Ocuphire Pharma Completes Transactions and Begins Trading on Nasdaq as OCUP
9:18am
424B3
12ria
2 Oct 20
Prospectus supplement
9:25am
S-4/A
ktr 50hv18fx
27 Aug 20
Registration of securities issued in business combination transactions (amended)
5:04pm
S-4
437z1aidk5 n4
6 Jul 20
Registration of securities issued in business combination transactions
4:08pm
8-K
EX-2.1
k6sgyo df3m
19 Jun 20
Rexahn and Ocuphire Enter into Definitive Merger Agreement
9:02am
425
EX-2.1
fepmyl21kos48
19 Jun 20
Business combination disclosure
9:00am